Loading...
Loading...
India's sodium imports from AUSTRALIA total $72.1K across 53 shipments from 15 foreign suppliers. BILCARE GCS INC. leads with $17.5K in import value; the top 5 suppliers together control 72.1% of this origin. Leading Indian buyers include AUROBINDO PHARMA LTD. This corridor reflects India's pharmaceutical import demand for sodium โ a diversified sourcing base with multiple active suppliers from AUSTRALIA.

BILCARE GCS INC. is the leading Sodium supplier from AUSTRALIA to India, with import value of $17.5K across 8 shipments. The top 5 suppliers โ BILCARE GCS INC., NEW LIFE MEDICALS (USA), INC., NEW LIFE MEDICALS (USA) INC, AKESA PTY LTD, PRO PHARMACEUTICALS GROUP PTY LTD โ collectively account for 72.1% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BILCARE GCS INC. | $17.5K | 8 | 24.3% |
| 2 |
| NEW LIFE MEDICALS (USA), INC. |
| $11.2K |
| 1 |
| 15.5% |
| 3 | NEW LIFE MEDICALS (USA) INC | $10.1K | 4 | 14.0% |
| 4 | AKESA PTY LTD | $9.4K | 4 | 13.0% |
| 5 | PRO PHARMACEUTICALS GROUP PTY LTD | $3.8K | 2 | 5.2% |
| 6 | NEWLIFE MEDICALS (USA). INC. | $2.8K | 8 | 3.9% |
| 7 | BILCARE GCS INC | $2.5K | 2 | 3.5% |
| 8 | SAVI CLINICALS FZ LLC | $2.3K | 2 | 3.1% |
| 9 | PRO PHARMACEUTICALS GROUP PTY LIMITED | $2.0K | 1 | 2.8% |
| 10 | PRO PHARMACEUTICALS GROUP PTY LTD. | $1.9K | 1 | 2.6% |
| 11 | SEED PHARMA PTY LTD | $1.8K | 1 | 2.5% |
| 12 | M/S. NEWLIFE MEDICALS (USA). INC | $1.4K | 1 | 1.9% |
| 13 | CLINECT PTY LTD | $1.3K | 1 | 1.7% |
| 14 | M S ACCORD HEALTHCARE PTY LTD | $1.2K | 2 | 1.6% |
| 15 | PRO PHARMACEUTICALS GROUP PTY LTD | $786 | 2 | 1.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD | $27.6K | 16 | 38.3% |
| 2 | FRESENIUS KABI ONCOLOGY LIMITED | $11.2K | 1 | 15.5% |
| 3 | STERISCIENCE SPECIALTIES PRIVATE LIMITED | $8.9K | 3 | 12.4% |
| 4 | GLENMARK PHARMACEUTICALS LIMITED | $6.4K | 4 | 8.9% |
| 5 | CONCORD BIOTECH LIMITED | $3.8K | 2 | 5.2% |
| 6 | INDOCO REMEDIES LIMITED | $3.4K | 1 | 4.8% |
| 7 | EMCURE PHARMACEUTICALS LIMITED | $2.8K | 8 | 3.9% |
| 8 | EUGIA PHARMA SPECIALITIES LIMITED | $2.3K | 2 | 3.1% |
| 9 | TORRENT PHARMACEUTICALS LTD | $1.8K | 1 | 2.5% |
| 10 | MILAN LABORATORIES (INDIA) PRIVATE LIMITED | $1.3K | 1 | 1.7% |
| 11 | INTAS PHARMACEUTICALS LTD | $1.2K | 2 | 1.6% |
| 12 | BIOLOGICAL E. LIMITED | $509 | 1 | 0.7% |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $388 | 3 | 0.5% |
| 14 | RPG LIFE SCIENCES LIMITED | $192 | 3 | 0.3% |
| 15 | DR REDDYS LABORATORIES LIMITED | $158 | 1 | 0.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Sodium suppliers from AUSTRALIA to India include BILCARE GCS INC., NEW LIFE MEDICALS (USA), INC., NEW LIFE MEDICALS (USA) INC. The leading supplier is BILCARE GCS INC. with import value of $17.5K USD across 8 shipments. India imported Sodium worth $72.1K USD from AUSTRALIA in total across 53 shipments.
India imported Sodium worth $72.1K USD from AUSTRALIA across 53 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Sodium sourced from AUSTRALIA include AUROBINDO PHARMA LTD, FRESENIUS KABI ONCOLOGY LIMITED, STERISCIENCE SPECIALTIES PRIVATE LIMITED. The largest buyer is AUROBINDO PHARMA LTD with $27.6K in imports across 16 shipments.
The total value of Sodium imports from AUSTRALIA to India is $72.1K USD, across 53 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
53 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists